Alert Indications, Safety, and Warnings

PERCEPT™ PC NEUROSTIMULATOR Neurostimulator for Deep Brain Stimulation Therapy

With the first and only available sensing technology in deep brain stimulation (DBS), the Percept™ PC device ushers in a new era of DBS therapy for Parkinson’s disease, essential tremor, dystonia,* obsessive-compulsive disorder (OCD),* and epilepsy.

DOWNLOAD BROCHURE
Closeup of the Percept PC neurostimulator for deep brain stimulation.
Alert Indications, Safety, and Warnings

Overview

Get a Sense of What's Possible

See DBS from a new perspective.

Play Video

PRODUCT DETAILS

Unprecedented Insights — Inside and Outside of the Clinic

Personalize DBS therapy for your patients using objective data combined with event capturing.

Configure patient events using the patient programmer. Track events over time and correlate events with brain signals using the clinician programmer.

BrainSense™ Technology

The Percept™ PC device features BrainSense™ technology designed to capture brain signals (local field potential, or LFP) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.†

You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects — to deliver personalized, data-driven treatment and adjust as patients' needs evolve.‡

Empower Your Patients

Easy-to-Adjust Stimulation Options

The DBS patient programmer is enhanced so patients can more easily and conveniently engage with their therapy.

Assign custom names to therapy groups so that patients can easily adjust their therapy to their desired activities.

Digital Diary

Configure up to four custom events — such as medication adherence, side effects, and experiencing on/off state — that your patients can capture digitally using the intuitive patient programmer.

    

View of home screen, group select feature, and events feature on the Percept PC patient programmer.

The only 3T and 1.5T MR Conditional DBS System

The Percept™ PC device adds full-body§ 3T MRI eligibility for DBS patients, so they may benefit from the cutting-edge medical imaging when they need it. Plus, using a bipolar therapy group allows therapy to be ON during an MRI scan.

Now clinicians can use MRI Eligibility workflow on the clinician programmer to check MRI eligibility, generate an eligibility report, and place a patient’s device into the appropriate state for an MRI exam.

Patients can use MRI Mode on their patient programmer for a streamlined path to conditionally safe‡‡ MRI scans§, without needing to visit the clinician managing their DBS therapy.

 

View of MRI mode screens on patient programmer and clinician programmer.
ACCESS IMPORTANT MRI INFO

Expanded Access to MRI

The expanded MRI eligibility of the Percept™ PC device supports the most prevalent and fastest-growing MRI modalities.1

Estimated Global MRI Systems Market:

Chart showing that 3.0T is estimated to grow to 30% by 2023.

Engineered for Patient Comfort

Modern and Ergonomic

Percept™ PC device is smaller and thinner than the previous generation Activa™ PC device, and features a modern, ergonomic design — offering enhanced comfort for patients.

  

The Percept PC device is 20% smaller and 20% thinner than the Active PC device. It also features a sleek, curved design.

Designed to Last Longer — and Keep You Informed

Percept™ PC device is smaller yet offers improved longevity.

Plus, its smart battery technology provides real-time prediction of remaining battery life,# so you and your patients can have elevated peace of mind when planning for a replacement device.

  

View of remaining battery life on patient programmer and clinician programmer screens.

Designed for Today and Tomorrow

The Percept™ PC device features our most advanced DBS technologies: proprietary cortex chipset, custom cutting-edge electronics, and embedded software for patented processing and analysis of brain signals.

The state-of-the-art Percept™ PC device is also designed to facilitate expanded capabilities in the future via software upgrades — so you’re prepared for what’s next in DBS.

The Percept PC device has up to 16 independently regulated stimulation channels, up to 6 noise-limiting sensing channels, and a cortex chipset.

    

PRODUCT SPECIFICATIONS

Compatible with:

  • Lead model 3387 – movement disorders and epilepsy
  • Lead model 3389 – movement disorders and epilepsy
  • Lead model 3391 – psychiatric disorders
  • Extension model 37086
  • Clinician programmer model CT900 (tablet) with  clinician programmer software application A610, and communicator model 8880T2
  • DBS Patient Programmer Model TH91D with patient programmer software application A620

Model Specifications

Model B35200
Battery Primary Cell
Weight 61g
Height 68mm
Length 51mm
Channels 2

 

PRODUCT SUPPORT

Clinician Services
800-328-0810

MANUALS AND MRI GUIDELINES

Search by product name or model number.

VISIT LIBRARY
*

Humanitarian Device: The effectiveness of this device for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.

†

Signals may not be present or measurable in all patients.

‡

Clinical benefits of brain sensing have not been established.

§

Medtronic DBS systems are MR Conditional, and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions: http://professional.medtronic.com/mri.

||

In overall device volume.

Refers to case thickness.

#

For median energy use in DBS for patients with Parkinson’s disease, with moderate (up to 2 months per year) BrainSense™ technology usage.

**

For median energy use in DBS for patients with Parkinson’s disease, with equivalent settings and no BrainSense™ technology usage.

††

Based on current actual battery level and therapy settings from last seven days.

‡‡

Under certain conditions.

1

BCC Research Report HLC078D: Medical Magnetic Resonance Imaging (MRI) Technologies and Global Markets (July 2018).